New @NEJM review on GLP-1 receptor agonists just out: effects on glucose, weight, cardiovascular outcomes, #MASLD and kidney outcomes but important questions remain about durability, lean mass (muscle + bone) loss, and long-term safety
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients
Initially, we determined whether pegvisomant treatment inhibits GH signaling in mice
Et ce cul, je veux le mettre en gage
Ask your doctor about concerns related to hypoglycemia when drinking alcohol while taking GLP-1 drugs like Ozempic, especially if youre taking other medicines to treat diabetes
However, when blood sugar is high, the activity of the hexosamine pathway increases, activating the Sp1 pathway